search
Back to results

Surgical Decompression for Diabetic Neuropathy in the Foot

Primary Purpose

Diabetic Polyneuropathy

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Surgery
Sponsored by
Timothy J. Best Medicine Professional Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetic Polyneuropathy focused on measuring Diabetic sensorimotor polyneuropathy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >18 years
  • Presence of Type 1 or 2 diabetes mellitus (fasting plasma glucose > 7 mmol/L or casual plasma glucose > 11.1 mmol/L and symptoms of diabetes or a 2hr plasma glucose in a 75g oral glucose tolerance test > 11.1 mmol/L)
  • Symptoms of paresthesias (including burning pain) or numbness present symmetrically in both feet, determined to be on a peripheral nerve basis
  • Total Neuropathy score of ≥ 2 based on symptoms, signs, and nerve conduction study abnormality
  • Average pain on Likert scale (range 0 - 10) ≥5
  • Good diabetic control with Hgb A1C < 8
  • Presence of Tinel's sign at the Tarsal Tunnel
  • Possession of valid Ontario Hospital Insurance Plan (OHIP) coverage

Exclusion Criteria:

  • Other types of diabetes mellitus (gestational, drug-induced, etc.)
  • Other cause of neuropathy than diabetes such as vasculitis, amyloidosis, toxic neuropathy, HIV, renal failure, alcohol abuse, etc. Pure entrapment neuropathy without evidence of DSP
  • Symptomatic lumbosacral spine disease
  • Symptomatic lower extremity vascular disease
  • Previous foot ulceration or amputation. Other contraindications to surgery such as significant ankle edema, venous stasis, morbid obesity, or previous surgery/injury which would be incompatible with appropriate wound healing
  • History of Peripheral Arterial Disease
  • HbA1c > 8.0 - Adults lacking capacity to consent, pregnant women, prisoners, non-English speakers who require an interpreter, and those unwilling or unable to participate in the full study follow-up

Sites / Locations

  • Sault Area Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Surgical decompression

Standard medical care

Arm Description

Surgical decompression of the common peroneal, tibial, and deep peroneal nerves

Standard diabetic care and medical care provided for diabetic sensorimotor polyneuropathy

Outcomes

Primary Outcome Measures

To determine if lower extremity nerve decompression in patients suffering from symptomatic diabetic peripheral neuropathy significantly alleviates pain.

Secondary Outcome Measures

Neuropathic Symptoms as measured by the Total Neuropathy Score (TNS)
Signs of peripheral neuropathy - two-point discriminations and pressure thresholds, vibration sensibility
Nerve Conduction Velocity
Quality of Life

Full Information

First Posted
October 16, 2009
Last Updated
May 4, 2016
Sponsor
Timothy J. Best Medicine Professional Corporation
Collaborators
The Physicians' Services Incorporated Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT01006915
Brief Title
Surgical Decompression for Diabetic Neuropathy in the Foot
Official Title
Surgical Peripheral Nerve Decompression for the Treatment of Diabetic Neuropathy in the Foot
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
March 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Timothy J. Best Medicine Professional Corporation
Collaborators
The Physicians' Services Incorporated Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to determine whether or not surgical decompression of the common peroneal, tibial, and deep peroneal nerves in the legs of persons with diabetic peripheral neuropathy is effective treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Polyneuropathy
Keywords
Diabetic sensorimotor polyneuropathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Surgical decompression
Arm Type
Experimental
Arm Description
Surgical decompression of the common peroneal, tibial, and deep peroneal nerves
Arm Title
Standard medical care
Arm Type
No Intervention
Arm Description
Standard diabetic care and medical care provided for diabetic sensorimotor polyneuropathy
Intervention Type
Procedure
Intervention Name(s)
Surgery
Intervention Description
Surgical decompression of the common peroneal, tibial, and deep peroneal nerves
Primary Outcome Measure Information:
Title
To determine if lower extremity nerve decompression in patients suffering from symptomatic diabetic peripheral neuropathy significantly alleviates pain.
Time Frame
0,3,6, and 12 months
Secondary Outcome Measure Information:
Title
Neuropathic Symptoms as measured by the Total Neuropathy Score (TNS)
Time Frame
0,3,6, and 12 months
Title
Signs of peripheral neuropathy - two-point discriminations and pressure thresholds, vibration sensibility
Time Frame
0 and 12 months
Title
Nerve Conduction Velocity
Time Frame
0 and 12 months
Title
Quality of Life
Time Frame
0,3,6, and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >18 years Presence of Type 1 or 2 diabetes mellitus (fasting plasma glucose > 7 mmol/L or casual plasma glucose > 11.1 mmol/L and symptoms of diabetes or a 2hr plasma glucose in a 75g oral glucose tolerance test > 11.1 mmol/L) Symptoms of paresthesias (including burning pain) or numbness present symmetrically in both feet, determined to be on a peripheral nerve basis Total Neuropathy score of ≥ 2 based on symptoms, signs, and nerve conduction study abnormality Average pain on Likert scale (range 0 - 10) ≥5 Good diabetic control with Hgb A1C < 8 Presence of Tinel's sign at the Tarsal Tunnel Possession of valid Ontario Hospital Insurance Plan (OHIP) coverage Exclusion Criteria: Other types of diabetes mellitus (gestational, drug-induced, etc.) Other cause of neuropathy than diabetes such as vasculitis, amyloidosis, toxic neuropathy, HIV, renal failure, alcohol abuse, etc. Pure entrapment neuropathy without evidence of DSP Symptomatic lumbosacral spine disease Symptomatic lower extremity vascular disease Previous foot ulceration or amputation. Other contraindications to surgery such as significant ankle edema, venous stasis, morbid obesity, or previous surgery/injury which would be incompatible with appropriate wound healing History of Peripheral Arterial Disease HbA1c > 8.0 - Adults lacking capacity to consent, pregnant women, prisoners, non-English speakers who require an interpreter, and those unwilling or unable to participate in the full study follow-up
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Timothy J Best, MD, MSc
Organizational Affiliation
Northern Ontario School of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sante Fratesi, MD, MSc
Organizational Affiliation
Northern Ontario School of Medicine
Official's Role
Study Director
Facility Information:
Facility Name
Sault Area Hospital
City
Sault Ste. Marie
State/Province
Ontario
ZIP/Postal Code
P6A 2C4
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Surgical Decompression for Diabetic Neuropathy in the Foot

We'll reach out to this number within 24 hrs